Y200-1164 Screening compound: N-(5-tert-butyl-1,2-oxazol-3-yl)-7-chloro-8-methyl-2-(pyridin-2-yl)quinoline-4-carboxamide

Y200-1164 Screening compound: N-(5-tert-butyl-1,2-oxazol-3-yl)-7-chloro-8-methyl-2-(pyridin-2-yl)quinoline-4-carboxamide
Y200-1164 Screening compound: N-(5-tert-butyl-1,2-oxazol-3-yl)-7-chloro-8-methyl-2-(pyridin-2-yl)quinoline-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound Y200-1164
N-(5-tert-butyl-1,2-oxazol-3-yl)-7-chloro-8-methyl-2-(pyridin-2-yl)quinoline-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

Y200-1164

Molecular Formula

C23H21ClN4O2 (C23 H21 ClN4 O2)

Compound Name

N-(5-tert-butyl-1,2-oxazol-3-yl)-7-chloro-8-methyl-2-(pyridin-2-yl)quinoline-4-carboxamide

IUPAC name

N-(5-tert-butyl-12-oxazol-3-yl)-7-chloro-8-methyl-2-(pyridin-2-yl)quinoline-4-carboxamide

SMILES

CC(C)(C)c1cc(NC(c2c(ccc(Cl)c3C)c3nc(-c3ncccc3)c2)=O)no1

InChI

InChI=1S/C23H21ClN4O2/c1-13-16(24)9-8-14-15(11-18(26-21(13)14)17-7-5-6-10-25-17)22(29)27-20-12-19(30-28-20)23(2,3)4/h5-12H,1-4H3,(H,27,28,29)

InChI Key

QKCWGPACWPETIE-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD05999255

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

420.9

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

6.250

Distribution Coefficient, logD

6.247

Water Solubility, LogSw

-6.12

Polar Surface Area

63.581

Acid Dissociation Constant (pKa)

9.50

Base Dissociation Constant (pKb)

3.44

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.70

Y200-1164 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Antiviral Library (67538 compounds)

CNS targets activity set (6557 compounds)

Human GPCR Annotated Library (5539 compounds)

Voltage-Gated Ion Channel-Targeted Library (4740 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

New Agro Library (44492 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Antiviral
  • Infections
  • Immune system
  • Nervous system
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Targets:
  • Kinases
  • Ion Channels
  • Kinases
Agro:
  • Agro

References: we are preparing a list of scientific research reports with Y200-1164 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound Y200-1164?
Check Price and Availability of Y200-1164, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of Y200-1164 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for Y200-1164
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for Y200-1164
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of Y200-1164 available by request